Noura Radwan

1.4k total citations
17 papers, 137 citations indexed

About

Noura Radwan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Noura Radwan has authored 17 papers receiving a total of 137 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 5 papers in Radiation. Recurrent topics in Noura Radwan's work include Prostate Cancer Treatment and Research (17 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Advanced Radiotherapy Techniques (5 papers). Noura Radwan is often cited by papers focused on Prostate Cancer Treatment and Research (17 papers), Prostate Cancer Diagnosis and Treatment (12 papers) and Advanced Radiotherapy Techniques (5 papers). Noura Radwan collaborates with scholars based in United States and Canada. Noura Radwan's co-authors include Phuoc T. Tran, Kenneth J. Pienta, Ryan Phillips, Curtiland Deville, Theodore L. DeWeese, Daniel Y. Song, Steven P. Rowe, Ashley E. Ross, Emmanuel S. Antonarakis and Martin G. Pomper and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Noura Radwan

17 papers receiving 136 citations

Peers

Noura Radwan
T Do United States
Christin A. Knowlton United States
Alex Hoyle United Kingdom
Kathryn Masi United States
Alexis Vrachimis Switzerland
T Do United States
Noura Radwan
Citations per year, relative to Noura Radwan Noura Radwan (= 1×) peers T Do

Countries citing papers authored by Noura Radwan

Since Specialization
Citations

This map shows the geographic impact of Noura Radwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noura Radwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noura Radwan more than expected).

Fields of papers citing papers by Noura Radwan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noura Radwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noura Radwan. The network helps show where Noura Radwan may publish in the future.

Co-authorship network of co-authors of Noura Radwan

This figure shows the co-authorship network connecting the top 25 collaborators of Noura Radwan. A scholar is included among the top collaborators of Noura Radwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noura Radwan. Noura Radwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Wang, Jue, Noura Radwan, Catherine H. Marshall, et al.. (2024). Assessment of Circulating Tumor Cells in Oligometastatic Castration-Sensitive Prostate Cancer Patients from the ORIOLE Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). S68–S68. 1 indexed citations
3.
Deek, Matthew P., Noura Radwan, Catherine H. Marshall, et al.. (2023). Prospective Characterization of Circulating Tumor Cells in Hormone Sensitive Oligometastatic Prostate Cancer Patients on a Metastasis-Directed Therapy Trial. International Journal of Radiation Oncology*Biology*Physics. 117(2). e367–e368. 1 indexed citations
4.
Sutera, Philip, Ryan Phillips, Noura Radwan, et al.. (2023). Prognostic impact of circulating tumor cells in oligometastatic hormone-sensitive prostate cancer following metastasis-directed therapy.. Journal of Clinical Oncology. 41(6_suppl). 199–199. 1 indexed citations
5.
Phillips, Ryan, Noura Radwan, Michael A. Gorin, et al.. (2019). Online Prostate-Specific Membrane Antigen and Positron Emission Tomography–Guided Radiation Therapy for Oligometastatic Prostate Cancer. Advances in Radiation Oncology. 5(2). 260–268. 13 indexed citations
6.
Peng, Luke, Amol Narang, Noura Radwan, et al.. (2018). Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy. Urologic Oncology Seminars and Original Investigations. 36(6). 309.e7–309.e14. 9 indexed citations
7.
Phillips, Ryan, Matthew P. Deek, Noura Radwan, et al.. (2018). Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment. World Journal of Urology. 37(12). 2623–2629. 20 indexed citations
8.
Tran, Phuoc T., Noura Radwan, Ryan Phillips, et al.. (2018). OC-0505: Interim results of a randomized trial of observation versus SABR for oligometastatic prostate cancer. Radiotherapy and Oncology. 127. S261–S261. 6 indexed citations
9.
Phillips, Ryan, Noura Radwan, Ashley E. Ross, et al.. (2018). Interim Results of a Randomized Trial of Observation Versus SABR for Castration-Sensitive Oligometastatic Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 102(3). e134–e135. 1 indexed citations
10.
Phillips, Ryan, Noura Radwan, Michael A. Gorin, et al.. (2018). PSMA-Directed Biologically-Guided Radiation Therapy of Castration-Sensitive Oligometastatic Prostate Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 102(3). S152–S152. 1 indexed citations
11.
Tran, Phuoc T., Ryan Phillips, Noura Radwan, et al.. (2018). SABR Produces Systemic Adaptive Immune Responses in Castration-Sensitive Oligometastatic Prostate Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 102(3). S24–S25. 2 indexed citations
12.
Narang, Amol, Noura Radwan, S.P. Robertson, et al.. (2017). End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer. Prostate Cancer and Prostatic Diseases. 20(2). 203–209. 2 indexed citations
13.
Radwan, Noura, Ryan Phillips, Ashley E. Ross, et al.. (2017). A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE). BMC Cancer. 17(1). 453–453. 68 indexed citations
14.
Tosoian, Jeffrey J., Ridwan Alam, Amol Narang, et al.. (2017). Unscreened older men diagnosed with prostate cancer are at increased risk of aggressive disease. Prostate Cancer and Prostatic Diseases. 20(2). 193–196. 5 indexed citations
15.
Phillips, Ryan, Noura Radwan, Ashley E. Ross, et al.. (2017). A phase II randomized trial of observation versus stereotactic ablative radiation for oligometastatic prostate cancer (ORIOLE).. Journal of Clinical Oncology. 35(15_suppl). TPS5094–TPS5094. 2 indexed citations
16.
Tran, Phuoc T., Ryan Phillips, Noura Radwan, et al.. (2017). Stereotactic ablative radiation therapy for the treatment of oligometastatic prostate cancer.. Journal of Clinical Oncology. 35(15_suppl). 5020–5020. 3 indexed citations
17.
Tran, Phuoc T., Noura Radwan, Ashley E. Ross, et al.. (2016). Stereotactic Ablative Radiation Therapy for the Treatment of Oligometastatic Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). E248–E248. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026